Multifaceted use of ProRoot MTA root canal repair material.
Mineral Trioxide Aggregate (MTA) is a new material recently approved by the FDA for use in pulpal therapy. MTA has been reported to have superior biocompatibility and sealing ability and is less cytotoxic than other materials currently used in pulpal therapy. This report is a review of MTA's physical and biological properties and the clinical techniques of direct pulp capping, apexification, and repair of failed calcium hydroxide therapy.
Schmitt
D
D
University of Southern California, USA. don_schmitt@msn.com
Lee
J
J
Bogen
G
G
D017607:Aluminum Compounds / Q000737:chemistry / Q000627:therapeutic use*; D001672:Biocompatible Materials / Q000737:chemistry; D017610:Calcium Compounds / Q000737:chemistry / Q000627:therapeutic use*; D002126:Calcium Hydroxide / Q000627:therapeutic use; D001840:Dental Bonding; D003785:Dental Pulp Capping; D004338:Drug Combinations; D006801:Humans; D010087:Oxides / Q000737:chemistry / Q000627:therapeutic use*; D012387:Root Canal Filling Materials / Q000737:chemistry / Q000627:therapeutic use*; D012390:Root Canal Therapy; D017640:Silicates / Q000737:chemistry / Q000627:therapeutic use*; D019227:Tooth Apex / Q000187:drug effects; D016896:Treatment Outcome
D017607:Aluminum Compounds; D001672:Biocompatible Materials; D017610:Calcium Compounds; D004338:Drug Combinations; D010087:Oxides; D012387:Root Canal Filling Materials; D017640:Silicates; C086631:mineral trioxide aggregate; D002126:Calcium Hydroxide